Anne F Luetkemeyer Selected Research

Anne F Luetkemeyer Research Topics

Disease

17	Infections 07/2023 - 10/2010
8	COVID-19 07/2022 - 01/2020
7	Sexually Transmitted Diseases (Sexually Transmitted Disease) 04/2024 - 01/2020
7	HIV Infections (HIV Infection) 06/2021 - 05/2011
7	Coinfection 01/2021 - 05/2011
7	Tuberculosis (Tuberculoses) 08/2017 - 05/2011
4	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 05/2011
4	Fibrosis (Cirrhosis) 01/2018 - 01/2016
4	Hepatitis 05/2017 - 04/2013
4	Opportunistic Infections (Opportunistic Infection) 05/2014 - 05/2011
3	Hepatitis C 01/2022 - 07/2014
3	Acquired Immunodeficiency Syndrome (AIDS) 08/2015 - 05/2011
2	Syphilis 04/2023 - 01/2020
2	Reinfection 01/2022 - 04/2019
2	Vitamin D Deficiency 04/2013 - 06/2012
2	Lipodystrophy 06/2012 - 05/2011
1	Non-alcoholic Fatty Liver Disease 11/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2023
1	Opioid-Related Disorders (Opiate Addiction) 07/2023
1	Gonorrhea 04/2023
1	Pneumonia (Pneumonitis) 12/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 12/2021
1	Fatty Liver 06/2021
1	Hepatocellular Carcinoma (Hepatoma) 06/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Chronic Hepatitis C 01/2018
1	Hepatitis B 05/2017
1	Pulmonary Tuberculosis 05/2016
1	Aortitis 08/2015
1	Immune Reconstitution Inflammatory Syndrome 04/2014
1	Virus Diseases (Viral Diseases) 04/2013
1	Viremia 11/2011
1	Neoplasms (Cancer) 05/2011

Drug/Important Bio-Agent (IBA)

11	Antiviral Agents (Antivirals)IBA 07/2023 - 05/2011
7	Doxycycline (Periostat)FDA LinkGeneric 04/2024 - 01/2020
4	RNA (Ribonucleic Acid)IBA 11/2023 - 07/2014
4	InterferonsIBA 12/2021 - 05/2014
4	SofosbuvirIBA 01/2021 - 07/2014
3	AcidsIBA 08/2017 - 04/2014
3	Nucleic AcidsIBA 08/2017 - 04/2014
3	Rifampin (Rifampicin)FDA LinkGeneric 05/2016 - 08/2013
2	Opioid Analgesics (Opioids)IBA 07/2023 - 01/2022
2	remdesivirIBA 12/2021 - 01/2021
2	Oxygen (Dioxygen)IBA 12/2021 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 05/2016
2	glecaprevir and pibrentasvirIBA 01/2021 - 01/2018
2	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 07/2014
2	Isoniazid (Ftivazide)FDA LinkGeneric 04/2014 - 10/2010
2	Biomarkers (Surrogate Marker)IBA 04/2013 - 06/2012
1	HDL CholesterolIBA 11/2023
1	C-Reactive ProteinIBA 11/2023
1	pitavastatin (itavastatin)FDA Link 11/2023
1	elbasvirIBA 07/2023
1	grazoprevirIBA 07/2023
1	Tetracycline (Achromycin)FDA LinkGeneric 04/2023
1	VaccinesIBA 01/2023
1	mRNA VaccinesIBA 07/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 07/2022
1	ChAdOx1 nCoV-19IBA 01/2022
1	Interferon beta-1a FDA Link 12/2021
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2021
1	baricitinibIBA 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2020
1	sofosbuvir drug combination ledipasvirIBA 01/2018
1	glecaprevirIBA 01/2018
1	pibrentasvirIBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 05/2017
1	Tenofovir (Viread)FDA Link 05/2017
1	Ritonavir (Norvir)FDA Link 01/2017
1	Darunavir (Prezista)FDA Link 01/2017
1	Atazanavir Sulfate (Reyataz)FDA Link 01/2017
1	Raltegravir Potassium FDA Link 01/2017
1	dasabuvirIBA 01/2017
1	ombitasvirIBA 01/2017
1	paritaprevirIBA 01/2017
1	dolutegravirIBA 01/2017
1	GoldIBA 05/2016
1	Tuberculin (PPD)IBA 05/2016
1	Culture MediaIBA 05/2016
1	DNA VaccinesIBA 02/2016
1	daclatasvirIBA 01/2016
1	16S Ribosomal RNAIBA 08/2015
1	Interferon-alpha (Interferon Alfa)IBA 03/2015
1	Protease Inhibitors (Protease Inhibitor)IBA 05/2014
1	efavirenz (Sustiva)FDA Link 08/2013
1	entecavir FDA Link 11/2011

Therapy/Procedure

15	Therapeutics 07/2023 - 10/2010
3	Art Therapy 11/2023 - 10/2011
3	Aftercare (After-Treatment) 01/2022 - 01/2018
2	Retreatment 01/2018 - 05/2016
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Opiate Substitution Treatment 01/2022
1	Liver Transplantation 01/2021
1	Duration of Therapy 01/2021
1	Noninvasive Ventilation 01/2021
1	Condoms (Condom) 01/2020